The defense as to the patent issue is that:

...those patents are currently pending and have not been rejected and do not directly conflict with patents held solely by the (Cytodyn)...

Is there any published document that supports the thesis that Cytodyn patents caused InCellDx patents to be declined?

Perhaps we will see more detail on Friday.